Glenmark Pharma eyes US biz to be strong growth driver
Glenmark Pharmaceuticals Tuesday said it is looking at strong growth in the US market and developing a pipeline of innovative products to offset weakness in emerging markets.
Sep 22, 2015, 21:39 PM IST
Glenmark gets nod from Russia for Salmecort MDI inhaler
Glenmark Pharmaceuticals has received approval for generic Salmecort MDI inhaler used for management of asthma and pulmonary disease from Russia's Ministry of Health.
Mar 12, 2015, 17:14 PM IST
Glenmark bullish on drug discovery pipeline, eyes partnerships
As many as six out of seven molecules in Glenmark's drug discovery pipeline are currently in the clinical trial stage and the company's R&D spend pegged at 10 percent of sales is expected to be maintained at similar levels for next two years, a top official has said.
Feb 15, 2015, 20:55 PM IST
Glenmark to set up first manufacturing facility in US
Glenmark Pharmaceuticals plans to set up its first manufacturing facility in the US at an estimated investment of over Rs 500 crore to cater to the North American market.
Jul 17, 2014, 17:37 PM IST
